Form 4: LeMaitre Vascular Inc. Chairman and CEO Reports Acquisition of Dividend Equivalent Rights
SEC Form 4
George W. LeMaitre, Chairman and CEO of LeMaitre Vascular Inc., reports the acquisition of dividend equivalent rights related to restricted stock unit awards.
Summary
- George W. LeMaitre, Chairman and CEO of LeMaitre Vascular Inc. (LMAT), filed a Form 4 on June 3, 2024, reporting transactions related to dividend equivalent rights.
- The transactions occurred on May 30, 2024, and involved the acquisition of dividend equivalent rights associated with previously granted restricted stock unit (RSU) and Performance Share Unit (PSU) awards.
- These dividend equivalent rights are economically equivalent to shares of LMAT common stock and vest proportionately with the underlying RSU and PSU awards.
- The acquired dividend equivalent rights are linked to RSU awards granted on December 20, 2019 (2.1735 rights), December 2, 2020 (4.0765 rights), December 11, 2021 (5.8814 rights), December 12, 2022 (8.9898 rights), and December 8, 2023 (10.246 rights), as well as a PSU award granted on December 12, 2022 (8.9898 rights).
- Following these transactions, LeMaitre directly owns 51.3374, 68.303, 73.1206, 64.4698, 63.7611 and 22.3788 dividend equivalent rights respectively.
Sentiment
Score: 6
Explanation: The document is a routine regulatory filing detailing the acquisition of dividend equivalent rights. It doesn't contain information that would significantly impact investor sentiment positively or negatively.
Positives
- The acquisition of dividend equivalent rights suggests continued alignment of the CEO's interests with those of shareholders.
- The vesting schedule of the rights is tied to the vesting of the underlying RSUs and PSUs, incentivizing long-term performance.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. The acquisition of dividend equivalent rights is a common practice for aligning executive compensation with shareholder returns.
Stakeholder Impact
- The acquisition of dividend equivalent rights aligns management's interests with shareholders by linking compensation to company performance.
Key Dates
| Date | Description |
|---|---|
| 12/20/2019 | Date of restricted stock unit award grant related to dividend equivalent rights. |
| 12/02/2020 | Date of restricted stock unit award grant related to dividend equivalent rights. |
| 12/11/2021 | Date of restricted stock unit award grant related to dividend equivalent rights. |
| 12/12/2022 | Date of restricted stock unit and performance share unit award grants related to dividend equivalent rights. |
| 12/08/2023 | Date of restricted stock unit award grant related to dividend equivalent rights. |
| 05/30/2024 | Date of transaction: Acquisition of dividend equivalent rights. |
| 06/03/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.